Shanghai - Delayed Quote CNY
Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)
94.30
-0.18
(-0.19%)
At close: June 6 at 3:00:04 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Jinhao Du | Chairman of the Board & GM | -- | -- | 1954 |
Mr. Jie Hu | Vice Chairman & Deputy GM | -- | -- | 1975 |
Mr. Lin Wang | Financial Director | -- | -- | 1983 |
Mr. Chen Huang | Marketing Manager | -- | -- | 1975 |
Mr. Feng Xu | Deputy GM & Director | -- | -- | 1965 |
Ms. Huafeng Shan | Chief Quality Officer | -- | -- | 1974 |
Mr. Huibing Luo | Chief Chemistry Officer | -- | -- | 1974 |
Ms. Shuo Li | Board Secretary | -- | -- | 1990 |
Quan Gan | Accounting Supervisor | -- | -- | -- |
Mr. Huayong Zhou | Deputy Director of R&D | -- | -- | 1984 |
Shanghai Allist Pharmaceuticals Co., Ltd.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 1,417
Description
Shanghai Allist Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in China. The company offers pharmaceuticals for the treatment of tumor and cancer diseases. Shanghai Allist Pharmaceuticals Co., Ltd. was founded in 2004 and is headquartered in Shanghai, China.
Corporate Governance
Shanghai Allist Pharmaceuticals Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 23, 2025 at 10:59 AM UTC
Shanghai Allist Pharmaceuticals Co., Ltd. Earnings Date
Recent Events
June 3, 2025 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
600161.SS TIANTAN BIO
20.15
+4.73%
688105.SS Nanjing Vazyme Biotech Co., Ltd
22.03
-1.26%
688331.SS RemeGen Co., Ltd.
61.00
-0.81%
138610.KQ NIBEC Co., Ltd.
27,200.00
-10.82%
688278.SS Xiamen Amoytop Biotech Co., Ltd.
73.64
-1.27%
688428.SS InnoCare Pharma Limited
24.56
+2.42%
688180.SS Shanghai Junshi Biosciences Co., Ltd.
33.09
-1.93%
688382.SS InventisBio Co., Limited
30.06
-0.03%
GYRE Gyre Therapeutics, Inc.
8.41
+5.52%
CAMX.ST Camurus AB (publ)
638.50
-0.62%